Something went wrong with the connection!

Manufacturing & Supply Chain

Biopharma & Life Sciences Connected Live conference and exhibition – Radisson Blu Hotel & Spa, Cork – January 25th 2023

 Breaking News

Biopharma & Life Sciences Connected Live conference and exhibition – Radisson Blu Hotel & Spa, Cork – January 25th 2023

Biopharma & Life Sciences Connected Live conference and exhibition – Radisson Blu Hotel & Spa, Cork – January 25th 2023
December 13
11:35 2022
Spread the love

Reflecting Ireland’s position as a centre of excellence in life sciences and biopharmaceutical production, the Biopharma & Life Sciences Connected Live Conference and Exhibition will be held on Wednesday, January 25th 2023 at the Radisson Blu Hotel & Spa in Cork.

The Conference will entail a full day’s schedule (9 am to 4.30 pm) of keynote addresses and panel debates featuring leading national and international experts involved in the R&D and manufacturing of biopharmaceutical and biotech products and its associated technology. Accompanied by an Exhibition area displaying the latest technology and research, Biopharma & Life Sciences Connected Live will highlight the latest developments in the sector.

Ireland has become one of the world’s leading manufacturers of medicines. The world’s ten leading pharmaceutical companies have all established substantial operations in Ireland. Five of the world’s eight top selling drugs are currently produced in Ireland and the country has become the third largest exporter of pharmaceuticals globally.

Supporting thousands of jobs and spread across the various regions, the Irish biopharmaceutical industry contributes significantly to both the national and local economies.

Winning Formula

The reasons for Ireland’s success in developing a thriving biopharmaceutical and life sciences sector are chiefly due to access to a well educated and talented workforce, the lower corporation tax regime, an economic environment that encourages R&D and innovation, along with a strong track record of both international and local companies operating successfully in the country.

IDA Ireland has played a key role in developing Ireland as a global pharmaceutical manufacturing and R&D hub and attracting Foreign Direct Investment (FDI) in the sector. About Eur2 billion is currently being invested in biopharma R&D by IDA client companies annually with an additional Eur1 billion in capital expenditure added each year.

Continued Capital Investment

The biopharmaceutical sector in Ireland is continuing to invest in future growth. For instance, Pfizer, the world’s largest biopharma company, is to invest more than €1.2 billion in its Grange Castle, Dublin manufacturing site. The investment, which is Pfizer’s biggest expansion investment to date in Ireland, will see a new facility built, which will double the capacity for biological drug substance manufacturing at the site. Pfizer was the first pharmaceutical manufacturing multinational company to locate in Ireland in 1969.

Ipsen Ireland recently launched and upgraded manufacturing site in Dublin after a €52 million investment. AstraZeneca is to invest €65 million in biologic manufacturing, research and development in Ireland at its sites in Dublin and Athlone.

Meanwhile, Eli Lilly plans to invest over €400 million in a new biopharmaceutical facility in Limerick. In County Cork, Janssen Sciences Ireland, part of the Johnson & Johnson family of companies, has announced a €150 million expansion of its biopharmaceutical supply chain facility in Ringaskiddy.

AbbVie has also recently announced a €60 million expansion at its Cork manufacturing site, which has just marked its 20th anniversary.

The National Institute for Bioprocessing Research and Training (NIBRT) has commenced construction work on an ambitious expansion of its existing facility in Dublin. The €21 million project will increase NIBRT’s capacity and capability to conduct manufacturing-focused research and training in advanced therapeutics.

Major Challenges

However, despite its successful track record, the biopharma sector in Ireland is currently experiencing significant challenges around supply chain issues, digital transformation, automation, carbon reduction and regulatory changes. Biopharma & Life Sciences Connected Live will address these issues and offer practical advice on how they can be successfully managed. The Event will allow visitors to meet with Government support agencies and associations, and to join in Q&A sessions with industry thought leaders. Of course, Biopharma & Life Sciences Connected Live will provide an excellent networking opportunity for attendees.

Key Topics

Key topics to be covered by Biopharma & Life Sciences Connected Live include:

* Research & Innovation

* Automation

* Vaccine Manufacturing

* Process Optimization

* Tech Transfer

* Digitalization

* IoT & Industry 4.0

* Covid 19 – Impact to the market

* Hybrid Systems – Single Use and/or Stainless Steel

* Biosimilars – Best-Practice

* Ultrafast Project Execution

* Turnkey

* HVAC & Cleanroom Engineering

* Cell & Gene Therapy.

Registration to attend Biopharma & Life Sciences Connected Live is now open. Register for free at: https://www.biotransformationevent.com/register/

The Organiser

In addition to producing successful business-to-business magazines for more than a quarter of a century, Dublin-based Premier Publishing & Events organises some of the largest conferences and exhibitions tailored to the specific requirements of industrial sectors such as manufacturing and its associated supply chain, construction, food & drink manufacturing, technology and biopharmaceuticals in the Republic of Ireland, Northern Ireland, England, Wales and Scotland.

About Author

mike

mike

Related Articles

Follow me on Twitter

 

New Subscriber

    Subscribe Here



    Advertisements


























    National Manufacturing Conference & Exhibition 2020

    NIBRT Springboard Success Stories